Cargando…
Acute Heart Failure Caused by Parvovirus B-19 Myocarditis Treated with Human Immunoglobulin
We describe the case of a 42-year-old woman developing cardiogenic shock with cardiac tamponade due to an acute myo-pericarditis caused by Parvovirus B19 (PVB19), successfully treated with intravenous (iv) immunoglobulin administration.
Autores principales: | Alberti, Luca, Loffi, Marco, Fragasso, Gabriele, Spoladore, Roberto, Ballarotto, Carlo, Margonato, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008535/ https://www.ncbi.nlm.nih.gov/pubmed/24826236 http://dx.doi.org/10.1155/2012/180871 |
Ejemplares similares
-
CARDIOGENIC SHOCK SECONDARY TO COVID 19 MYOCARDITIS: PECULIARITIES ON DIAGNOSIS, HISTOLOGY AND TREATMENT
por: Fiore, Giorgio, et al.
Publicado: (2021) -
Case report of cardiogenic shock in COVID-19 myocarditis: peculiarities on diagnosis, histology, and treatment
por: Fiore, Giorgio, et al.
Publicado: (2021) -
A Case of Fetal Parvovirus B19 Myocarditis That Caused Terminal Heart Failure
por: Hichijo, Atsuko, et al.
Publicado: (2014) -
Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertension
por: Spoladore, Roberto, et al.
Publicado: (2017) -
A Unique Case of Mitral Valve Double Papillary Muscle Rupture
por: Pannone, Luigi, et al.
Publicado: (2019)